Pharmaceutical ETF

Fund Name:
Pharmaceutical ETF
Van Eck
Total Net Assets:
Related Index:
MVIS US Listed Pharmaceutical 25 Index
ETF Category: 
Expense Ratio: 
Net Asset Value: 
Recent NAV Premium: 
NAV Symbol: 
Number of Holdings: 
Annualized Yield: 
Annualized Distribution: 
PPH Dividend History » 
Stock Weight Amount
Abbvie 6.40% $10,720,522
Novo Nordisk A/S 5.95% $9,962,423
Astrazeneca Plc 5.70% $9,541,986
Glaxosmithkline Plc 5.69% $9,527,531
Sanofi 5.54% $9,276,156
List of all 25 stocks held by PPH »
Quotes delayed 20 minutes

Buy (3.06 out of 4)
44th percentile
(ranked lower than approx. 56% of all etfs covered)
Based on data provided by Zacks Investment Research via
ETF Assets
GDX   $11,033,101,682
EMLC   $4,980,729,321
GDXJ   $4,252,991,675
HYD   $3,193,503,045
MOAT   $2,934,458,695
List of all 50 others »
Shares Short 2,560,000
Chg. from Last Month -10,000
Shares Outstanding 3,038,138
% of Shares Short 84.26%
Days to Cover 28.4
Based on third party short interest data.

PPH | Pharmaceutical ETF | ETF Channel |

Copyright © 2010 - 2019, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.